Australia - inglés - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - fluconazole, quantity: 200 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - fluconazole injection is indicated for the following conditions but should be used only when fluconazole cannot be administered orally: 1. treatment of cryptococcal meningitis in patients who are unable to tolerate amphotericin b. note: data suggest that the clinical efficacy of fluconazole is lower than that of amphotericin b in the treatment of the acute phase of cryptococcal meningitis. 2. maintenance therapy to prevent relapse of cryptococcal meningitis in patients with acquired immune deficiency syndrome (aids). 3. treatment of oropharyngeal and oesophageal candidiasis in patients with aids and other immunosuppressed patients. 4. secondary prophylaxis of oropharyngeal candidiasis in patients with human immunodeficiency virus (hiv) infection. 5. serious and life-threatening candida infections in patients who are unable to tolerate amphotericin b. note: it remains to be shown that fluconazole is as effective as amphotericin b in the treatment of serious and life-threatening candida infections. until such data are available, amphotericin b remains the drug of choice.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - bupivacaine hydrochloride, quantity: 1.25 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 1.32 mg/ml); fentanyl citrate, quantity: 7.9 microgram/ml (equivalent: fentanyl, qty 5 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - marcain 0.125% with fentanyl is intended for post-operative or obstetric epidural analgesia.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxicillin trihydrate, quantity: 3.4 g (equivalent: amoxicillin, qty 3 g) - powder, oral - excipient ingredients: sucrose; ammonium glycyrrhizinate; sodium citrate dihydrate; saccharin sodium; sodium benzoate; xanthan gum; disodium edetate; flavour - indications as at 10 february 2005: it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: note: therary should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e.coli (see microbiology). respiratory (acute and chronic): h.influenzae, streptococcus; spneumoniae; staphylococcus, non-penicillinase-producing; e.coli (see microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see microbiology), p.mirabilis and s.faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxil may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan, quantity: 100 mg (equivalent: sumatriptan succinate, qty 140 mg) - tablet, film coated - excipient ingredients: magnesium stearate; calcium hydrogen phosphate; sodium bicarbonate; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; hypromellose; triacetin - indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of imigran in the treatment of basilar or hemiplegic migraine.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan succinate, quantity: 70 mg (equivalent: sumatriptan, qty 50 mg) - tablet, film coated - excipient ingredients: sodium bicarbonate; calcium hydrogen phosphate; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; hypromellose; triacetin; iron oxide red - indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of imigran in the treatment of basilar or hemiplegic migraine.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - cefuroxime axetil, quantity: 150 mg (equivalent: cefuroxime, qty 125 mg) - suspension, powder for - excipient ingredients: aspartame; stearic acid; sucrose; povidone; xanthan gum; acesulfame potassium; flavour - zinnat suspension is indicated for the treatment of the following mild to moderately severe infections caused by sensitive bacteria in paediatric patients aged 3 months to 12 years: tonsillitis and pharyngitis, acute bacterial otitis media. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefuroxime axetil appears to be as effective as phenoxymethylpenicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefuroxime axetil in the subsequent prevention of rheumatic fever are not available at present.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - cefuroxime axetil -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan succinate, quantity: 16.8 mg/ml (equivalent: sumatriptan, qty 12 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride - sumatriptan (imigran) tablets, injection and nasal spray are indicated for the acute relief of migraine attacks with or without aura. sumatriptan (imigran) injection is also indicated for the acute treatment of cluster headaches. there is no information available on the use of imigran injection in the treatment of basilar or hemiplegic migraine.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan succinate, quantity: 16.8 mg/ml (equivalent: sumatriptan, qty 12 mg/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections - sumatriptan (imigran) tablets, injection and nasal spray are indicated for the acute relief of migraine attacks with or without aura. sumatriptan (imigran) injection is also indicated for the acute treatment of cluster headaches. there is no information available on the use of imigran injection in the treatment of basilar or hemiplegic migraine.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan, quantity: 100 mg/ml - spray, solution - excipient ingredients: sulfuric acid; monobasic potassium phosphate; purified water; dibasic sodium phosphate; sodium hydroxide - imigran s nasal spray is indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of imigran s in the treatment of basilar or hemiplegic migraine.